Use of prescription Cyclo-Oxygenase 2 inhibitors (COX-2) and Non COX-2 Non- Steroidal Anti-Inflammatory Drugs (NSAID) in a UK population

Sep-05

AUTHORS : Prof Kenneth J Rothman, Boston University School of Public Health, 715 Albany St Talbot Building, Boston MA 02118 – Email: krothman@bu.edu – Profile: https://profiles.bu.edu/Kenneth.Rothman AND https://www.bumc.bu.edu/busm/profile/kenneth-rothman/ AND (RTI Profile) https://www.rtihs.org/research-team/kenneth-j-rothman

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 14(S2):S141

DOI : 10.1002/pds.1136

Use of prescription Cyclo-Oxygenase 2 inhibitors (COX-2) and Non COX-2 Non- Steroidal Anti-Inflammatory Drugs (NSAID) in a UK population

More publications

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study

Target Serum Urate Achievement and Chronic Kidney Disease Progression in Patients With Gout and Kidney Disease